BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30624640)

  • 1. Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas.
    Riccardi A; Aspir T; Shen L; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Parham K; Carling T; Costa-Guda J; Arnold A
    J Clin Endocrinol Metab; 2019 Jun; 104(6):1948-1952. PubMed ID: 30624640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GCM2 Variants in Familial and Multiglandular Primary Hyperparathyroidism.
    Vincze S; Peters NV; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Riccardi A; Parham K; Carling T; Costa-Guda J; Arnold A
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2021-e2026. PubMed ID: 34967908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Glial Cells Missing-2 (GCM2) variants in parathyroid disorders.
    Canaff L; Guarnieri V; Kim Y; Wong BYL; Nolin-Lapalme A; Cole DEC; Minisola S; Eller-Vainicher C; Cetani F; Repaci A; Turchetti D; Corbetta S; Scillitani A; Goltzman D
    Eur J Endocrinol; 2022 Feb; 186(3):351-366. PubMed ID: 35038313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism.
    Guan B; Welch JM; Sapp JC; Ling H; Li Y; Johnston JJ; Kebebew E; Biesecker LG; Simonds WF; Marx SJ; Agarwal SK
    Am J Hum Genet; 2016 Nov; 99(5):1034-1044. PubMed ID: 27745835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased prevalence of the GCM2 polymorphism, Y282D, in primary hyperparathyroidism: analysis of three Italian cohorts.
    D'Agruma L; Coco M; Guarnieri V; Battista C; Canaff L; Salcuni AS; Corbetta S; Cetani F; Minisola S; Chiodini I; Eller-Vainicher C; Spada A; Marcocci C; Guglielmi G; Zini M; Clemente R; Wong BY; de Martino D; Scillitani A; Hendy GN; Cole DE
    J Clin Endocrinol Metab; 2014 Dec; 99(12):E2794-8. PubMed ID: 25279501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnicity of Patients With Germline
    Guan B; Welch JM; Vemulapalli M; Li Y; Ling H; Kebebew E; Simonds WF; Marx SJ; Agarwal SK
    J Endocr Soc; 2017 May; 1(5):488-499. PubMed ID: 29264504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specifying the molecular pattern of sporadic parathyroid tumorigenesis-The Y282D variant of the GCM2 gene.
    Marchiori E; Pelizzo MR; Herten M; Townsend DM; Rubello D; Boschin IM
    Biomed Pharmacother; 2017 Aug; 92():843-848. PubMed ID: 28609842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of GCMB, a parathyroid-specific transcription factor, in parathyroid adenoma of primary hyperparathyroidism.
    Mannstadt M; Holick E; Zhao W; Jüppner H
    J Endocrinol; 2011 Aug; 210(2):165-71. PubMed ID: 21642377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline Mutations Related to Primary Hyperparathyroidism Identified by Next-Generation Sequencing.
    Park HS; Lee YH; Hong N; Won D; Rhee Y
    Front Endocrinol (Lausanne); 2022; 13():853171. PubMed ID: 35586626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure.
    El Lakis M; Nockel P; Guan B; Agarwal S; Welch J; Simonds WF; Marx S; Li Y; Nilubol N; Patel D; Yang L; Merkel R; Kebebew E
    Surgery; 2018 Jan; 163(1):31-34. PubMed ID: 29108698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline GCM2 Mutation Screening in Chinese Primary Hyperparathyroidism Patients.
    Song A; Yang Y; Wang Y; Liu S; Nie M; Jiang Y; Li M; Xia W; Wang O; Xing X
    Endocr Pract; 2020 Oct; 26(10):1093-1104. PubMed ID: 33471711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GCM2 Silencing in Parathyroid Adenoma Is Associated With Promoter Hypermethylation and Gain of Methylation on Histone 3.
    Singh P; Bhadada SK; Dahiya D; Saikia UN; Arya AK; Sachdeva N; Kaur J; Behera A; Brandi ML; Rao SD
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e4084-e4096. PubMed ID: 34077544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should the GCM2 gene be tested when screening for familial primary hyperparathyroidism?
    Coppin L; Dufosse M; Romanet P; Giraud S; North MO; Cardot Bauters C; Borson-Chazot F; Duchesne L; Métallo M; Lovecchio T; Barlier A; Odou MF
    Eur J Endocrinol; 2020 Jan; 182(1):57-65. PubMed ID: 31671402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas.
    Costa-Guda J; Soong CP; Parekh VI; Agarwal SK; Arnold A
    Horm Cancer; 2013 Oct; 4(5):301-7. PubMed ID: 23715670
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Szalat A; Shpitzen S; Pollack R; Mazeh H; Durst R; Meiner V
    Front Endocrinol (Lausanne); 2023; 14():1254156. PubMed ID: 38130397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas.
    Costa-Guda J; Marinoni I; Molatore S; Pellegata NS; Arnold A
    J Clin Endocrinol Metab; 2011 Apr; 96(4):E701-6. PubMed ID: 21289244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Underexpression of Gcm2, a master regulatory gene of parathyroid gland development, in adenomas of primary hyperparathyroidism.
    Correa P; Akerström G; Westin G
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):501-5. PubMed ID: 12354132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary Hyperparathyroidism.
    van der Tuin K; Tops CMJ; Adank MA; Cobben JM; Hamdy NAT; Jongmans MC; Menko FH; van Nesselrooij BPM; Netea-Maier RT; Oosterwijk JC; Valk GD; Wolffenbuttel BHR; Hes FJ; Morreau H
    J Clin Endocrinol Metab; 2017 Dec; 102(12):4534-4540. PubMed ID: 29040582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
    Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas.
    Newey PJ; Nesbit MA; Rimmer AJ; Attar M; Head RT; Christie PT; Gorvin CM; Stechman M; Gregory L; Mihai R; Sadler G; McVean G; Buck D; Thakker RV
    J Clin Endocrinol Metab; 2012 Oct; 97(10):E1995-2005. PubMed ID: 22855342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.